Delivery Order SPE2DB22D3401-SPE2DB25FT3EC
Award Date
4/14/25
Potential Completion Date
4/15/25
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,742.41, is a Firm Fixed Price Delivery Order to provide 4,567,531,331 tablets of the drug Letrozole 2.5 mg. The contract has an ultimate completion date of March 12, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999,...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,411.05, is for the delivery of Letrozole 2.5 mg tablets in 90-count packages. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of April 14, 2025. This award does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,042.98 firm fixed-price delivery order is for the supply of 4,567,558,074 units of the drug Letrozole 2.5 mg tablets in 90-count packages. The award has an ultimate completion date of March 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,709,355 units of the drug Letrozole 2.5 mg tablet in 90-count packages. The contract has a ceiling value of $2,163.36 and an ultimate completion date of December 13, 2024. It is a delivery order contract with a firm fixed price. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,688.02 firm fixed-price delivery order is for the supply of 90-tablet bottles of the drug Letrozole 2.5 mg. The contract has a ceiling value of $9,688.02 and an ultimate completion date of May 21, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,966.87, is for the supply of Letrozole 2.5 mg tablets to support federal healthcare programs. The contract is a firm-fixed-price arrangement with a completion date of December 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $2,318.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order to supply 4566490525 - Letrozole 2.5 mg Tablets in 90-count packages. The award has an Ultimate Completion Date of November 20, 2024 and a Firm Fixed Price pricing type. This contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $3,363.91 firm-fixed-price contract is for the delivery of 90 tablets of the medication Letrozole 2.5 mg. The contract has a completion date of May 28, 2025 and is not set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,774.22, is a delivery order for the supply of Letrozole 2.5 mg tablets. The contract is not designated as a set-aside and has an ultimate completion date of May 12, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,800.88, is for the delivery of Letrozole 2.5 mg tablets in 30-count packages. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...